except you're no Joe Kennedy , you're barely an average Joe ...
The Amedica website has a job posting 3 days ago :
Amedica Salt Lake City, UT
Posted 3 days ago in Marketing/PR
Basic Job Functions
Product Manager (PM) is responsible for product development, promotions and management of assigned product lines in the Amedica Portfolio.
The PM will be responsible for working closely to implement marketing campaigns, in order to reach sales objectives, for assigned Amedica product segments.
The position requires healthcare knowledge, particularly of the spine and/or orthopedic market, and the ability to work with surgeons to understand opportunities and find innovative solutions for the broader market. The PM will work closely with sales, product development and other team members to accomplish sales goals and is required to communicate with all areas of the company.
After reading that article , I'm left scratching my head at the fuzzy math that he's using to justify that the $1 Billion paid by Celgene which gives them 10% of Juno is not what it seems. If you paid 1 Billion for 10% that means you perceive the value to be $10 Billion with the expectation that it will go higher (or else why would you buy it ) . With the current market cap at about $5 Billion , Celgene believes the current value potential to be at least twice as much . You can slice and dice it whichever way you like but that is the deal that was made . Where the market value will be a year or 5 years from now is something else to speculate on . If they succeed it'll look like a bargain just like if they fail it'll look like an expensive gamble but regardless , their perceived value as of today is $1 Billion for 10% of JUNO.
won't profit from this trade next week. You really think they'll let you cash in on this tellegraphed play. Neither calls or puts will make you money tomorrow. You heard it here first.....
A chance to invest in a noble cause to fight cancer and make some good return on your investment. what more can you ask for , an investment you can truly feel good about.
what analyst would say that ? if Celgene pays $93 a share and deal is signed already who in their right mind would say something like that ....
can i just send you my address and you can mail me the check for the amount you plan to lose tomorrow..
so so you have to register that you're more than a 10% owner of the company ?
they need price over $1 to avoid delisting , 180 day notice sent in February. The float is 26 mill shares about $15 million give or take. The institution and insiders can easily buy the large blocks and take it out of circulation to get price above $1 . They're in effect shrinking the float which now might be only 20 million shares. Since it recently IPO'ed I don't think the investment house or insiders will want to see this happen, if FDA issues approval then you might see $2, $3, $4, or even $5 . The buyout potential then goes into play by someone like Zimmer hldgs ZMH after all this is so cheap even at $3 to $5 market cap would be about $200 mill to $250 mill . That's my thought on this but do your own research and GL.